STOCK TITAN
  1. Home
  2. Sec-filings
  3. NRBO
  4. [EFFECT] NeuroBo Pharmaceuticals, Inc. Common Stock SEC Filing

[EFFECT] NeuroBo Pharmaceuticals, Inc. Common Stock SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 10, 2025 5:00 P.M.
Form: S-3
CIK: 0001638287
Company Name: MetaVia Inc.
File Number: 333-288486

Source: View Original Filing on SEC EDGAR

Stock NRBO logo
Neurobo Pharmaceuticals Inc

NASDAQ:NRBO

NRBO Rankings

#6055 Ranked by Market Cap
N/A Ranked by Dividends

NRBO Latest News

Jan 15, 2026
Why Integrity Now Has to Be Built, Not Declared - and How SMX Fits That Reality
Nov 18, 2024
NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases
Nov 13, 2024
NeuroBo Pharmaceuticals to Participate in Investor Conferences in November
Nov 7, 2024
NeuroBo Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Nov 4, 2024
NeuroBo Pharmaceuticals Completes Last Patient Last Visit in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH

NRBO Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G/A] NeuroBo Pharmaceuticals, Inc. Common Stock SEC Filing
Aug 13, 2025
[Form 4] NeuroBo Pharmaceuticals, Inc. Common Stock Insider Trading Activity
Aug 7, 2025
[8-K] NeuroBo Pharmaceuticals, Inc. Common Stock Reports Material Event
Aug 7, 2025
[10-Q] NeuroBo Pharmaceuticals, Inc. Common Stock Quarterly Earnings Report
Aug 7, 2025
[8-K] NeuroBo Pharmaceuticals, Inc. Common Stock Reports Material Event

NRBO Stock Data

20.33M
3.00M
Pharmaceutical Preparation Manufacturing
Pharmaceutical Preparations
US
CAMBRIDGE